| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
9 companies
Opaleye Management Inc. is a 10% Owner at OCUL with holdings across 9 companies. Recent SEC Form 4 filings include 12 buys and 11 sells.
Estimated insider holdings value: $124.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | CDXS Codexis, Inc. | 10% Owner | Sell | 1,082,459 | $1.94 | $2,101,031.57 | -4.8% | -35.2% | - | |
| Nov 11, 2025 | CDXS Codexis, Inc. | 10% Owner | Sell | 1,063,211 | $1.76 | $1,868,198.13 | -2.8% | -28.3% | - | |
| Oct 6, 2025 | SNWV Sanuwave Health, Inc. | 10% Owner | Buy | 1,267 | $30.28 | $38,360.96 | +0.1% | -28.5% | - | |
| Aug 4, 2025 | CDXS Codexis, Inc. | 10% Owner | Buy | 85,000 | $2.68 | $227,920.90 | +0.3% | -20.4% | -50.7% | |
| Jul 30, 2025 | CDXS Codexis, Inc. | 10% Owner | Buy | 10,000 | $2.82 | $28,160.55 | - | -7.2% | -47.0% | |
| Jul 18, 2025 | CDXS Codexis, Inc. | - | Buy | 100,000 | $2.82 | $282,000.00 | +0.8% | -6.4% | -20.6% | |
| Jun 27, 2025 | CDXS Codexis, Inc. | 10% Owner | Buy | 100,000 | $2.39 | $239,000.00 | +0.8% | +0.4% | +0.0% | |
| Jun 16, 2025 | CDXS Codexis, Inc. | 10% Owner | Buy | 250,000 | $2.24 | $560,008.98 | +0.7% | +8.9% | +10.7% | |
| Jun 10, 2025 | ETON Eton Pharmaceuticals, Inc. | 10% Owner | Buy | 7,930 | $15.82 | $125,483.53 | +0.3% | +13.2% | +85.4% | |
| Jun 10, 2025 | HROW Harrow, Inc. | 10% Owner | Sell | 30,204 | $30.59 | $923,827.13 | -13.4% | +27.6% | - |